AstraZeneca warns of Frequent Autoimmune Diseases through Vaccination

Updated: Aug 20, 2021

A so-called red hand letter recently sent by AstraZeneca warns of the dangerous consequences of the genetic vector vaccine known as “Vaxzevria”. The pharmaceutical company estimates that “immune-induced thrombocytopenia” occurs frequently, ie in 1 to 10 percent of those vaccinated. And that already after the first dose. This means that there is a constant risk of dangerous thrombosis and bleeding in vaccinated people.


30th April 2021

Thrombocytopenia is a lack of blood platelets, which are mainly responsible for hemostasis and blood clotting. Since the deficiency is "immune-induced", it is an autoimmune disease that remains lifelong, as I know from my own experience. It is triggered by antibodies against platelet factor 4. This means that your own antibodies render platelets harmless. The body remembers how these antibodies are to be formed and the disease can therefore recur over a long period of time, as is the case with autoimmune diseases.


So far, these PF4 antibodies have been found in all vaccinated people diagnosed with thrombocytopenia. Other vaccinated subjects were not tested for this or for the D-dimer thrombosis indicator. So nobody knows how widespread this autoimmune disease and the tendency to thrombosis actually is. Experts like Sucharit Bhakdi and Wolfgang Wodarg have been warning against this for months and are calling for these investigations to be carried out more widely.

AstraZeneca writes that not much is known yet and that research is still needed. Nevertheless, on page 2 of the letter, one comes to the following conclusion:

"According to information from experts, it can be assumed that a disorder similar to atypical heparin-induced thrombocytopenia (aHIT) is the most plausible hypothesis, given the similarities in the serological profile as well as in the clinical symptoms and course in the affected patients. It is considered likely that the syndrome, which resembles aHIT, is triggered by an autoantibody with a high binding affinity for PF4 [platelet factor 4]. It is believed that the antibody could alter the structure of PF4, similar to what has been shown for aHIT. It was also found that high titers of anti-PF4 antibodies were observed in all patients whose serum was analyzed, which supports this hypothesis.


While further data is being collected, the PRAC has recommended that the Vaxzevria product information be updated to reflect current knowledge on this safety issue. One of these updates concerns section 4.8 of the SmPC, thrombocytopenia was inserted as an adverse reaction with a frequency of common based on data from clinical trials. Furthermore, thrombosis in combination with thrombocytopenia was recorded with a frequency of very rarely. "

This is further specified in the information sheet of the PEI:


"A decrease in the number of blood platelets (thrombocytopenia), vomiting, diarrhea, reddening and swelling of the injection site and fever were observed frequently (between 1% and 10%)."

These findings and assumptions essentially stem from the investigations carried out by Prof. Anreas Greinacher's team from the University of Greifswald. Thrombocytopenia occurs when either too few platelets are formed or too many platelets have been used up in the course of blood clotting or when platelets are destroyed by antibodies. The latter is called "immune thrombocytopenia" or "immune-induced thrombocytopenia" (ITP) because the antibodies are part of the immune system. On the other hand, you can take drugs that suppress the immune system.


Autoimmune reactions can get out of control due to various stimuli. For example, through a renewed infection with any of the widespread coronaviruses. Through injuries, shocks, weakened immune systems and the like. Vaccinated people are therefore exposed to permanent danger.


Since the PF4 antibodies were only measured in a very limited group of people, it is not known how widespread the problem is. It may just as easily be present in 100% of those vaccinated. In addition, according to the pharmaceutical association Pharmig, only 6% of serious side effects are actually reported and included in the databases.

And one more thing: the problem is by no means limited to the AstraZenecca preparation, but also occurs with all other preparations. And not only with humans. On December 1st, 2020 I reported about an item of information that I sent from Austrian veterinarians by email:


"Covid-19 looks almost like the FIP with us! In feline infectious peritonitis (also caused by a coronavirus) there are these infection-intensifying antibodies and I stopped vaccinating the cats because there was an increased incidence of serious illnesses. "

The previously known mechanisms


In fact, more is known than Astrazeneca and the Paul Ehrlich Institute (PEI) claim to know. Sucharit Bhakdi has clarified basic mechanisms in a previously published chapter of his new book


The massive side effects and possible as yet unknown long-term damage are due to the nature of the genetic engineering vaccines. The inoculated particles are supposed to penetrate into body cells and then let the antigen of the virus, in this case the typical spike protein, be generated by the human cell so that the immune system is trained on it and specific T and B cells as well as subsequently the B cells are supposed to produce the antibodies. Only a small part of the vaccine affects muscle cells, the rest of a billion gene packages go to the lymph nodes and the bloodstream. This makes them right


8 views0 comments